Retroperitoneal Lymph Node Metastases

Chapter

Abstract

Many malignant tumors produce retroperitoneal nodal metastases. Retroperitoneal metastases may be secondary to squamous cell carcinoma of pelvic, urinary, or gynecological systems, gastrointestinal (GI) tract adenocarcinoma, renal cell carcinoma, and unknown origin. Up to now, we have treated 17 cases of retroperitoneal metastatic cancer, including metastatic adenocarcinoma, squamous cell carcinoma, and sarcoma. Metastatic tumors that mostly occur in the retroperitoneal lymph nodes and lymph tissue may be differentiated from primary retroperitoneal tumors that commonly arise from the connective tissue beyond the lymph nodes.

References

  1. Briasoulis E, Pavlidis N. Cancer of unknown primary origin. Oncologist. 1997;2(3):142–52.PubMedGoogle Scholar
  2. Burghardt E, Pickel H, Lahousen M, Stettner H. Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol. 1986;155(2):315–9.CrossRefGoogle Scholar
  3. Chen SS, Lee L. Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gynecol Oncol. 1983;16(1):95–100.CrossRefGoogle Scholar
  4. Coulier B, Lefebvre Y, de Visscher L, et al. Metastases of clinically occult testicular seminoma mimicking primary extragonadal retroperitoneal germ cell tumors. JBR-BTR. 2008;91(4):139–44.PubMedGoogle Scholar
  5. Fox RM, Woods RL, Tattersall MH, et al. Undifferentiated carcinoma in young men: the atypical teratoma syndrome. Lancet. 1979;1(8130):1316–8.CrossRefGoogle Scholar
  6. Greco FA, Vaughn WK, Hainsworth JD. Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome. Ann Intern Med. 1986;104(4):547–53.CrossRefGoogle Scholar
  7. Hainsworth JD. Poorly differentiated neuroendocrine carcinoma of unknown primary site. Ann Intern Med. 1988;109(5):364.CrossRefGoogle Scholar
  8. Hilton S, Herr HW, Teitcher JB, et al. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. Am J Roentgenol. 1997;169(2):521–5.CrossRefGoogle Scholar
  9. Hogeboom WR, Hoekstra HJ, Mooyaart EL, et al. Magnetic resonance imaging of retroperitoneal lymph node metastases of non-seminomatous germ cell tumours of the testis. Eur J Surg Oncol. 1993;19(5):429–37.PubMedGoogle Scholar
  10. Karsell PR, Sheedy PF, O’Connell MJ. Computed tomography in search of cancer of unknown origin. JAMA. 1982;248(3):340–3.CrossRefGoogle Scholar
  11. Knapp RC, Friedman EA. Aortic lymph node metastases in early ovarian cancer. Am J Obstet Gynecol. 1974;119(8):1013–7.CrossRefGoogle Scholar
  12. Levi F, Te VC, Erler G, Randimbison L, et al. Epidemiology of unknown primary tumors. Eur J Cancer. 2002;38(13):1810–2.CrossRefGoogle Scholar
  13. McMillan JH, Levine E, Stephens RH. Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. A retrospective study. Radiology. 1982;143(1):143–6.CrossRefGoogle Scholar
  14. Parada D, Peña KB, Moreira O, Cohen I, Parada AM, Mejías LD. Extragonadal retroperitoneal germ cell tumor: primary versus metastases? Arch Esp Urol. 2007;60(6):713–9.CrossRefGoogle Scholar
  15. Richardson RL. The unrecognized extragonadal germ cell cancer syndrome. Ann Intern Med. 1981;94(2):181.CrossRefGoogle Scholar
  16. Richardson RL, Greco FA, Wolff S, et al. Extragonadal germ cell malignancy: value of tumor markers in metastatic carcinoma in young men. Proc Am Soc Clin Oncol. 1979;20:204.Google Scholar
  17. Ries LAG, Young TL, Keel GE, Eisner MP, Lin YD, Horner M-J. SEER Survival monograph: cancer survival among adults: U.S. SEER program, 1988–2001, patient and tumor characteristics. SEER program, NIH Pub. No. 07–6215. Bethesda, MD: National Cancer Institute; 2007.Google Scholar
  18. Scholz M, Zehender M, Thalmann GN, et al. Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis. Ann Oncol. 2002;13(1):121–4.CrossRefGoogle Scholar
  19. Van der Gaast A, Verweij J, Henzen-Logmans SC, et al. Carcinoma of unknown primary: identification of a treatable subset. Ann Oncol. 1990;1(2):119–22.CrossRefGoogle Scholar
  20. Wu PC, Lang JH, Huang RL, et al. Lymph node metastasis and retroperitoneal lymphadenectomy in ovarian cancer. Baillieres Clin Obstet Gynaecol. 1989;3(1):143–55.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2018

Authors and Affiliations

  1. 1.Peking University International HospitalBeijingChina

Personalised recommendations